American Shared Hospital Services Announces Proposed 2019 CMS Proton Therapy and Gamma Knife Reimbursement Rates
July 30 2018 - 8:03AM
Business Wire
Increases of around 2.6% for Proton Therapy
and 2.9% for Gamma Knife Proposed
American Shared Hospital Services (NYSE American: AMS) (the
"Company"), a leading provider of turnkey technology solutions for
advanced radiosurgical and radiation therapy services, announced
today that the Centers for Medicare and Medicaid Services (CMS) has
posted its proposed Medicare hospital outpatient prospective
payment rates for calendar year 2019.
CMS’s proposed 2019 proton therapy delivery code rates per daily
session are $530.43, a 1.6% increase ($522.31 in 2018) for a simple
treatment without compensation, and $1,081.08, a 2.6% increase
($1,053.52 in 2018) for a simple treatment with compensation, or an
intermediate or a complex treatment.
Also, CMS is proposing a 2.9% increase in the comprehensive
reimbursement rate for the Gamma Knife in 2019.
CMS will accept comments on these proposals until September 24,
2018 and will publish final rates in late 2018 to be effective
January 1, 2019.
About AMS:
American Shared Hospital Services provides turnkey technology
solutions for advanced radiosurgical and radiation therapy
services. AMS is the world leader in providing Gamma Knife
radiosurgery equipment, a non-invasive treatment for malignant and
benign brain tumors, vascular malformations and trigeminal
neuralgia (facial pain). The Company also offers proton therapy,
and the latest IGRT and IMRT systems.
Safe Harbor Statement:
This press release may be deemed to contain certain
forward-looking statements with respect to the financial condition,
results of operations and future plans of American Shared Hospital
Services (including statements regarding the expected continued
growth in volume of the MEVION S250 system, the expansion of the
Company's proton therapy business, and the timing of treatments by
new Gamma Knife systems) which involve risks and uncertainties
including, but not limited to, the risks of variability of
financial results between quarters, the risks of the Gamma Knife
and radiation therapy businesses, the risks of developing The
Operating Room for the 21st Century program, and the risks of the
timing, financing, and operations of the Company’s proton therapy
business. Further information on potential factors that could
affect the financial condition, results of operations and future
plans of American Shared Hospital Services is included in the
filings of the Company with the Securities and Exchange Commission,
including the Company's Annual Report on Form 10-K for the year
ended December 31, 2017, its quarterly report on Form 10-Q for the
three months ended March 31, 2018 and the definitive Proxy
Statement for the Annual Meeting of Shareholders held on June 14,
2018.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180730005127/en/
American Shared Hospital ServicesErnest A. Bates, M.D.,
(415) 788-5300Chairman and Chief Executive
Officereabates@ashs.comPCG Advisory Group, Investor
RelationsVivian CervantesP:
646-863-6274vivian@pcgadvisory.com
American Shared Hospital... (AMEX:AMS)
Historical Stock Chart
From Aug 2024 to Sep 2024
American Shared Hospital... (AMEX:AMS)
Historical Stock Chart
From Sep 2023 to Sep 2024